The Food and Drug Administration (FDA) has finally given its seal of approval to Owlet’s baby monitoring sock, two years after halting sales due to concerns over the device’s accuracy.
The Owlet Smart Sock 2 uses pulse oximetry to track a baby’s heart rate and oxygen levels, sending alerts to parents if levels fall outside of the normal range. The device has been praised by parents for providing peace of mind and allowing them to monitor their baby’s health while they sleep.
The FDA’s approval is a significant milestone for Owlet, which has faced criticism and legal challenges over its claims of accuracy. With the green light from the FDA, the company can now resume sales of the device and continue to innovate in the baby monitoring space.